Nykode Therapeutics ASA Free Cash Flow Generation Index

Latest as of March 2022: 0.85x

Nykode Therapeutics ASA free cash flow generation index. Nykode Therapeutics ASA (NYKD) has a Free Cash Flow Generation Index of 0.85x as of March 2022. Free cash flow of Nkr82.09 Million represents 1% of operating cash flow (Nkr96.14 Million).

FCF Generation Index

0.85x

Free Cash Flow / Operating CF

Free Cash Flow

Nkr82.09 Million

NOK

Operating Cash Flow

Nkr96.14 Million

NOK

Capital Expenditures

Nkr14.06 Million

NOK

Free Cash Flow Generation Index of Nykode Therapeutics ASA (2020–2021)

Free cash flow generation index of Nykode Therapeutics ASA from 2020 to 2021. Historical FCF Generation Index trend for Nykode Therapeutics ASA across 2 annual periods. See Nykode Therapeutics ASA (NYKD) flexibility index to measure the company's free cash flow as a share of total liabilities.

Nykode Therapeutics ASA Free Cash Flow Generation Index by Year (2020–2021)

Nykode Therapeutics ASA free cash flow generation index by year from 2020 to 2021. Year-by-year Free Cash Flow Generation Index for Nykode Therapeutics ASA. For the full cash flow conversion analysis, see Nykode Therapeutics ASA cash flow conversion.

Year	FCG Index	Free Cash Flow (NOK)	Operating CF	Capital Expenditures	YoY Change
2021	0.25x	Nkr284.00K	Nkr1.16 Million	Nkr871.00K	▼ -75.4%
2020	1.00x	Nkr180.17 Million	Nkr180.27 Million	Nkr99.00K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).